Zhao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhao Li has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- John B. Matson
Department of Chemistry and Macromolecules Innovation Institute Virginia Tech Blacksburg Virginia USA
4 shared publications - Yin Wang
Engineering Research Center of Cell & Therapeutic Antibody, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China
3 shared publications Ethan W. Winckler
Department of of Chemistry Virginia Tech Center for Drug Discovery Macromolecules Innovation Institute Virginia Tech Blacksburg VA 24061 USA
2 shared publications- Kearsley M. Dillon
Department of of Chemistry Virginia Tech Center for Drug Discovery Macromolecules Innovation Institute Virginia Tech Blacksburg VA 24061 USA
2 shared publications Bushra Tousian
Department of Chemistry and Macromolecules Innovation Institute
1 shared publicationClark Vu
Department of Chemistry and Macromolecules Innovation Institute
1 shared publication
Latest Publications
- Open Access
- 8 August 2025
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 7 (9) , 3141-3149
Cellular Uptake and Antioxidant Activity of H2S-Releasing Tetrapeptide Supramolecular Polymer Nanostructures
- 8 August 2025
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 7 (9) , 3141-3149
Open AccessCellular Uptake and Antioxidant Activity of H2S-Releasing Tetrapeptide Supramolecular Polymer Nanostructures
- 3 May 2022
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (10) , 4635-4651
pH-Responsive Self-Assembling Peptide-Based Biomaterials: Designs and Applications
Stimuli-responsive peptide-based biomaterials are increasingly gaining interest for various specific and targeted treatments, including drug delivery and tissue engineering. Among all stimuli, pH can be especially useful because endogenous pH changes are often associated with abnormal microenvironments. pH-Responsive amino acids and organic linkers can be easily incorporated into peptides that self-assemble into various nanostructures. Thus, these largely biocompatible and easily tunable platforms are ideal candidates for drug release and as fibrous materials capable of mimicking the native extracellular matrix. In this review, we highlight common design motifs and mechanisms of pH-responsiveness in self-assembling peptide-based biomaterials, focusing on recent advances of these biomaterials applied in drug delivery and tissue engineering. Finally, we suggest future challenges and areas for potential development in pH-responsive self-assembling peptide-based biomaterials.
- 3 May 2022
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (10) , 4635-4651
pH-Responsive Self-Assembling Peptide-Based Biomaterials: Designs and Applications
Stimuli-responsive peptide-based biomaterials are increasingly gaining interest for various specific and targeted treatments, including drug delivery and tissue engineering. Among all stimuli, pH can be especially useful because endogenous pH changes are often associated with abnormal microenvironments. pH-Responsive amino acids and organic linkers can be easily incorporated into peptides that self-assemble into various nanostructures. Thus, these largely biocompatible and easily tunable platforms are ideal candidates for drug release and as fibrous materials capable of mimicking the native extracellular matrix. In this review, we highlight common design motifs and mechanisms of pH-responsiveness in self-assembling peptide-based biomaterials, focusing on recent advances of these biomaterials applied in drug delivery and tissue engineering. Finally, we suggest future challenges and areas for potential development in pH-responsive self-assembling peptide-based biomaterials.
- 23 July 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (38) , 16698-16704
Alleviating Cellular Oxidative Stress through Treatment with Superoxide‐Triggered Persulfide Prodrugs
Overproduction of superoxide anion (O2.−), the primary cellular reactive oxygen species (ROS), is implicated in various human diseases. To reduce cellular oxidative stress caused by overproduction of superoxide, we developed a compound that reacts with O2.− to release a persulfide (RSSH), a type of reactive sulfur species related to the gasotransmitter hydrogen sulfide (H2S). Termed SOPD‐NAC, this persulfide donor reacts specifically with O2.−, decomposing to generate N‐acetyl cysteine (NAC) persulfide. To enhance persulfide delivery to cells, we conjugated the SOPD motif to a short, self‐assembling peptide (Bz‐CFFE‐NH2) to make a superoxide‐responsive, persulfide‐donating peptide (SOPD‐Pep). Both SOPD‐NAC and SOPD‐Pep delivered persulfides/H2S to H9C2 cardiomyocytes and lowered ROS levels as confirmed by quantitative in vitro fluorescence imaging studies. Additional in vitro studies on RAW 264.7 macrophages showed that SOPD‐Pep mitigated toxicity induced by phorbol 12‐myristate 13‐acetate (PMA) more effectively than SOPD‐NAC and several control compounds, including common H2S donors.
- 23 July 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (38) , 16698-16704
Alleviating Cellular Oxidative Stress through Treatment with Superoxide‐Triggered Persulfide Prodrugs
Overproduction of superoxide anion (O2.−), the primary cellular reactive oxygen species (ROS), is implicated in various human diseases. To reduce cellular oxidative stress caused by overproduction of superoxide, we developed a compound that reacts with O2.− to release a persulfide (RSSH), a type of reactive sulfur species related to the gasotransmitter hydrogen sulfide (H2S). Termed SOPD‐NAC, this persulfide donor reacts specifically with O2.−, decomposing to generate N‐acetyl cysteine (NAC) persulfide. To enhance persulfide delivery to cells, we conjugated the SOPD motif to a short, self‐assembling peptide (Bz‐CFFE‐NH2) to make a superoxide‐responsive, persulfide‐donating peptide (SOPD‐Pep). Both SOPD‐NAC and SOPD‐Pep delivered persulfides/H2S to H9C2 cardiomyocytes and lowered ROS levels as confirmed by quantitative in vitro fluorescence imaging studies. Additional in vitro studies on RAW 264.7 macrophages showed that SOPD‐Pep mitigated toxicity induced by phorbol 12‐myristate 13‐acetate (PMA) more effectively than SOPD‐NAC and several control compounds, including common H2S donors.
- 26 June 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (38) , 16841-16847
Alleviating Cellular Oxidative Stress through Treatment with Superoxide‐Triggered Persulfide Prodrugs
Overproduction of superoxide anion (O2.−), the primary cellular reactive oxygen species (ROS), is implicated in various human diseases. To reduce cellular oxidative stress caused by overproduction of superoxide, we developed a compound that reacts with O2.− to release a persulfide (RSSH), a type of reactive sulfur species related to the gasotransmitter hydrogen sulfide (H2S). Termed SOPD‐NAC, this persulfide donor reacts specifically with O2.−, decomposing to generate N‐acetyl cysteine (NAC) persulfide. To enhance persulfide delivery to cells, we conjugated the SOPD motif to a short, self‐assembling peptide (Bz‐CFFE‐NH2) to make a superoxide‐responsive, persulfide‐donating peptide (SOPD‐Pep). Both SOPD‐NAC and SOPD‐Pep delivered persulfides/H2S to H9C2 cardiomyocytes and lowered ROS levels as confirmed by quantitative in vitro fluorescence imaging studies. Additional in vitro studies on RAW 264.7 macrophages showed that SOPD‐Pep mitigated toxicity induced by phorbol 12‐myristate 13‐acetate (PMA) more effectively than SOPD‐NAC and several control compounds, including common H2S donors.
- 26 June 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (38) , 16841-16847
Alleviating Cellular Oxidative Stress through Treatment with Superoxide‐Triggered Persulfide Prodrugs
Overproduction of superoxide anion (O2.−), the primary cellular reactive oxygen species (ROS), is implicated in various human diseases. To reduce cellular oxidative stress caused by overproduction of superoxide, we developed a compound that reacts with O2.− to release a persulfide (RSSH), a type of reactive sulfur species related to the gasotransmitter hydrogen sulfide (H2S). Termed SOPD‐NAC, this persulfide donor reacts specifically with O2.−, decomposing to generate N‐acetyl cysteine (NAC) persulfide. To enhance persulfide delivery to cells, we conjugated the SOPD motif to a short, self‐assembling peptide (Bz‐CFFE‐NH2) to make a superoxide‐responsive, persulfide‐donating peptide (SOPD‐Pep). Both SOPD‐NAC and SOPD‐Pep delivered persulfides/H2S to H9C2 cardiomyocytes and lowered ROS levels as confirmed by quantitative in vitro fluorescence imaging studies. Additional in vitro studies on RAW 264.7 macrophages showed that SOPD‐Pep mitigated toxicity induced by phorbol 12‐myristate 13‐acetate (PMA) more effectively than SOPD‐NAC and several control compounds, including common H2S donors.
- 1 January 2006
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 38 (12) , 2064-2073
Downregulation of cAMP-dependent protein kinase inhibitor γ is required for BMP-2-induced osteoblastic differentiation
- 1 January 2006
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 38 (12) , 2064-2073
Downregulation of cAMP-dependent protein kinase inhibitor γ is required for BMP-2-induced osteoblastic differentiation